Brief: Amneal Receives U.S. FDA Approval For Iohexol Injection
13/11/2025 21:03
Nov 13 (Reuters) - Amneal Pharmaceuticals Inc AMRX.O: AMNEAL RECEIVES U.S. FDA APPROVAL FOR IOHEXOL INJECTION AMNEAL PHARMA: EXPECTS TO LAUNCH PRODUCT IN Q1 OF 2026. Source text: ID:nGNX7ChBdk Further company coverage: AMRX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Amneal Pharmaceuticals
See all newsUS RESEARCH ROUNDUP-3M Company, Constellation Energy, Metropolitan Bank Holding
US FDA is working with manufacturers to boost estrogen patch supply amid access concerns (updated)
U.S. RESEARCH ROUNDUP- Intuit, MongoDB, Zscaler
U.S. STOCKS ON THE MOVE-Mastercard, Yum, Equinix
Amneal Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary